In part one of this piece I summarized performances for my small pharma investment choices in my January 11th, 2012 piece on " Top of the Class Biotechs for 2012 ". Of the four companies presented about a year ago, two choices pretty much had a disastrous year in 2012 while the other two had an outstanding year.
http://seekingalpha.com/article/1118281-top-of-the-class-small-pharma-investments-for-2013-part-ii?source=feed
http://seekingalpha.com/article/1118281-top-of-the-class-small-pharma-investments-for-2013-part-ii?source=feed
No comments:
Post a Comment